VALIDOGEN, formerly known as VTU Technology, is a leading Austrian contract research and development company. VALIDOGEN offers UNLOCK PICHIA - the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein production. Founded in 2008, the company emerged to a globally recognized player in the field of Pichia pastoris based protein expression. VALIDOGEN has established a broad range of tools and know-how for the generation of high-performance Pichia processes. Exclusive proprietary technologies and profound experience of the VALIDOGEN team lead to competitive production processes for a wide range of recombinant proteins. Headquartered in Raaba-Grambach, near Graz, Austria, VALIDOGEN is a private company and independent subsidiary of the KonValue Holding GmbH.
We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions.
VERDI Solutions GmbH, a Vienna-based startup, develops cutting-edge technology for personalized cancer vaccines. Our innovations include diagnostic tests for HLA-based T-cell responses, HLA expression analysis, and personalized vaccine target identification. Our proprietary software predicts the immunogenicity, safety, and quality of vaccines at the individual level. Our mission is to provide safe, effective personalized vaccines to improve the health of cancer patients.
ViraTherapeutics is a biotechnology company developing a new class of immunotherapy drugs based on oncolytic (cancer-destroying) viruses. Since 2018 ViraTherapeutics is part of the Boehringer Ingelheim group of companies and is embedded in the corporate Discovery Research organization.
ViruSure was founded in 2005 to offer a range of biosafety testing services to biopharmaceutical product manufacturers. We offer a wide range of biosafety testing services to meet all relevant pathogen safety testing requirements. We focus on cell line characterization, mycoplasma testing, prion testing, tumorigenicity testing, oncogenicity studies, cell identity testing, mycobacteria testing, cell bank testing and virus bank testing.
Vivaldi Biosciences is developing its DeltaFLU influenza vaccine to provide broad cross-protection and superior efficacy in the prophylaxis of seasonal and pandemic influenza. DeltaFLU is composed of influenza vaccine strains genetically modified by deletion of the gene for nonstructural protein 1.
Vienna Textile Lab fabricates organic colours made by naturally occurring bacteria in order to provide the most sustainable, wholesome and environmentally friendly alternative to conventional synthetic colours. Using Vienna Textile Lab colours to dye your textiles means to act responsible and thoughtful. We help designers use new type of materials, methods and concepts in the textile business. Vienna Textile Lab makes dyeing go easy on human and ecological resources.
YASARA Biosciences develops and distributes the YASARA molecular modelling and simulation program. This acronym stands for Yet Another Scientific Artificial Reality Application, and delineates the software's main purpose: to create an artificial reality inside the computer, atom by atom, visualize it in 3D and let the user interact with it. The focus has always been on biomolecular modelling, covering the most prominent topics (including structure prediction and docking).
Our mission is to make a novel therapeutic approach a reality in Peritoneal Dialysis (PD) – an area where clinicians and patients saw disappointingly little innovation in decades. Zytoprotec, a biomedical company founded in 2007, has consistently moved its lead product – PDprotec® – from basic research through preclinical and clinical development. The product is currently prepared to enter a pivotal Phase III clinical trial.
Complex Pharmaceuticals ist ein pharmazeutisches Unternehmen in Wien, das sich auf die Herstellung, die sekundäre Verpackung und den Großhandel von Arzneimitteln spezialisiert hat. Mit einem klaren Fokus auf Effizienz, Präzision und Qualität bietet das Unternehmen innovative Lösungen entlang der gesamten pharmazeutischen Wertschöpfungskette.